SAN FRANCISCO - Bruker Corporation (NASDAQ:BRKR) has acquired AST Revolution, LLC, a developer of rapid antimicrobial susceptibility testing solutions, according to a press release statement from ...
The FDA has approved Avance® (acellular nerve allograft-arwx) for the treatment of sensory nerve discontinuity.
The U.S. FDA granted accelerated approval for the Biologics License Application for Axogen Inc.'s Avance, an acellular nerve allograft that serves as a scaffold for nerve regrowth, for treatment of ...
Avance Biosciences opened its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company’s capabilities in potency and functional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback